Headache News and Research

Latest Headache News and Research

FDA expands Hizentra administration options for people with primary immunodeficiency

CSL Behring announced today that the U.S. Food and Drug Administration has expanded the administration options for Hizentra, Immune Globulin Subcutaneous (Human), 20% Liquid, to include dosing once every two weeks (biweekly) for people diagnosed with primary immunodeficiency.

28 Sep 2013

First Edition: September 27, 2013

Today's headlines include the latest updates on the congressional brinksmanship related to current budget battles and efforts to defund the health law, as well as reports about President Barack Obama's campaign-style speech about the law and details on another implementation delay.

27 Sep 2013

Clinical decision rule may help doctors identify patients with headache in emergency department

Researchers have developed a simple clinical decision rule that may help doctors identify patients with headache in the emergency department who have subarachnoid hemorrhage (bleeding in a certain area of the brain), according to a study in the September 25 issue of JAMA.

25 Sep 2013

Study evaluates outcomes of youth athletes after sports-related concussion

Recent scientific findings have raised the fear that young athletes may fare worse after sustaining a sports-related concussion than older athletes. Researchers from Vanderbilt University School of Medicine compared symptoms associated with concussion in middle/high school-age athletes with those in college-age athletes to determine whether age-related differences exist.

25 Sep 2013

Quartette tablets now available in U.S. for prevention of pregnancy

Teva Women's Health, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd., today announced that the recently approved Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets are now available via prescription in the U.S. for the prevention of pregnancy.

24 Sep 2013

Boehringer Ingelheim, Lilly present post-hoc analysis data from linagliptin clinical trials at EASD 2013

Boehringer Ingelheim and Eli Lilly and Company today announced results from two post-hoc, pooled analyses of data from placebo-controlled clinical trials, which examined the safety of the dipeptidyl peptidase-4 inhibitor linagliptin in adults with type 2 diabetes.

24 Sep 2013

FDA approves STELARA (Ustekinumab) for treatment of active psoriatic arthritis

Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved STELARA® (ustekinumab) alone or in combination with methotrexate for the treatment of adult patients (18 years or older) with active psoriatic arthritis.

23 Sep 2013

Undersize school chairs, low desks and overweight backpacks contribute to chronic back pain in adolescents

Undersize school chairs, low desks and overweight backpacks are contributing to chronic back pain in adolescents, according to a study from researchers in Portugal to be published in the International Journal of Human Factors and Ergonomics.

23 Sep 2013

More AIDS-defining illnesses and severe side effects occur with appropriate comparator therapy

The drug combination of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil (elvitegravir fixed combination, trade name: Stribild) has been approved in Germany since May 2013 for the treatment of adults infected with human immunodeficiency virus type 1 (HIV-1).

21 Sep 2013

Smokers with a history of major depressive disorder (MDD) taking varenicline have significantly higher likelihood of quitting smoking than placebo

Results of a Pfizer-commissioned study published this month in Annals of Internal Medicine reveal that smokers with a past or present diagnosis of major depressive disorder (MDD)* taking varenicline had a significantly higher likelihood of quitting smoking (after 12 weeks and at 52 weeks) than those who were given a placebo.

18 Sep 2013

Women with acute coronary syndrome less likely to have chest pain than men

A higher proportion of women than men 55 years and younger did not have chest pain in acute coronary syndromes (ACS, such as heart attacks or unstable angina), although chest pain was the most common symptom for both sexes, according to a study published by JAMA Internal Medicine, a JAMA Network publication.

17 Sep 2013

Oil spill exposure appears to play role in development of hematologic and hepatic toxicity

A new study reports that workers exposed to crude oil and dispersants used during the Gulf oil spill cleanup display significantly altered blood profiles, liver enzymes, and somatic symptoms compared to an unexposed control group.

17 Sep 2013

Using large doses of codeine may heighten sensitivity to pain

Using large and frequent doses of the pain-killer codeine may actually produce heightened sensitivity to pain, without the same level of relief offered by morphine, according to new research from the University of Adelaide.

13 Sep 2013

Hospira announces EC approval of Inflectra, Europe's first biosimilar mAb therapy

Hospira, the world's leading provider of injectable drugs and infusion technologies, today announced the European Commission (EC) approval of Inflectra™ (infliximab), Europe's first biosimilar monoclonal antibody (mAb) therapy. Inflectra has been approved for the treatment of inflammatory conditions including rheumatoid arthritis (RA), ankylosing spondylitis, Crohn's disease (CD), ulcerative colitis (UC), psoriatic arthritis (PsA) and psoriasis.

10 Sep 2013

"Millions Suffer, Few Understand" encourages patients to talk openly about IC/BPS

This September, patients around the world will unite to share their personal stories and struggles with interstitial cystitis / bladder pain syndrome (IC/BPS). The 2013 theme, "Millions Suffer, Few Understand" encourages patients and providers to talk openly about this common yet often misunderstood pelvic pain condition.

5 Sep 2013

Health law subsidies present calculation challenges

The Wall Street Journal reports on the challenges of calculating future income and health insurance subsidies -- both of which will have an impact on the health law's new insurance marketplaces. Meanwhile, The Washington Post reports on how executive-branch and legislative-branch employees will have different experiences with the overhaul.

31 Aug 2013

First Edition: August 30, 2013

Today's headlines include the latest news on congressional efforts to avert a financial crisis as well as coverage of the news from the Internal Revenue Service, Treasury Department and Department of Health and Human Services about how same-sex marriage will be recognized.

30 Aug 2013

European Commission approves Stivarga tablets for treatment of patients with mCRC

Bayer HealthCare and Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) announced today that the European Commission has approved Stivarga® (regorafenib) tablets for the treatment of adult patients with metastatic colorectal cancer (mCRC).

30 Aug 2013

BP and headache drug effectively speeds up treatment of TB

Infectious disease experts at Johns Hopkins have found, in studies in mice, that a drug better known as a treatment for high blood pressure and headaches effectively speeds up treatment of TB when added to the standard, daily antibiotic regimen. Test animals were cured in four months instead of the usual six.

30 Aug 2013

Study reveals relationship between migraine and low income status

Studies show that migraine is more common among people with lower incomes. This relationship is examined in a study published in the August 28, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology, looking at whether developing migraines limits people's educational and career achievements, leading to a lower income status, or whether problems related to low income such as stressful life events and poor access to health care increase the likelihood of developing migraines.

29 Aug 2013

Headache News and Research

Latest Headache News and Research

FDA expands Hizentra administration options for people with primary immunodeficiency

First Edition: September 27, 2013

Clinical decision rule may help doctors identify patients with headache in emergency department

Study evaluates outcomes of youth athletes after sports-related concussion

Quartette tablets now available in U.S. for prevention of pregnancy

Boehringer Ingelheim, Lilly present post-hoc analysis data from linagliptin clinical trials at EASD 2013

FDA approves STELARA (Ustekinumab) for treatment of active psoriatic arthritis

Undersize school chairs, low desks and overweight backpacks contribute to chronic back pain in adolescents

More AIDS-defining illnesses and severe side effects occur with appropriate comparator therapy

Smokers with a history of major depressive disorder (MDD) taking varenicline have significantly higher likelihood of quitting smoking than placebo

Women with acute coronary syndrome less likely to have chest pain than men

Oil spill exposure appears to play role in development of hematologic and hepatic toxicity

Using large doses of codeine may heighten sensitivity to pain

Hospira announces EC approval of Inflectra, Europe's first biosimilar mAb therapy

"Millions Suffer, Few Understand" encourages patients to talk openly about IC/BPS

Health law subsidies present calculation challenges

First Edition: August 30, 2013

European Commission approves Stivarga tablets for treatment of patients with mCRC

BP and headache drug effectively speeds up treatment of TB

Study reveals relationship between migraine and low income status

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Headache News and Research

Latest Headache News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in